We found 372 records for "Regulatory / compliance"

Articles

Achieving market access in the UK with a little help from Patient Access Schemes

17th July 2014

 Achieving market access in the UK with a little help from Patient Access Schemes Articles

Gaining access to the UK market is increasingly about achieving a 'yes' from NICE. And for over 40 products, having a Patient Access Scheme (PAS) in place has helped companies...

Read more

Pharma gets social: FDA guidance on twitter is irrelevant for global pharma

16th July 2014

 Pharma gets social: FDA guidance on twitter is irrelevant for global pharmaArticles

Daniel Ghinn investigates the implications of FDA draft guidance.In June this year, the US FDA issued draft guidance for healthcare companies on how to tweet and conduct search advertising for...

Read more

The fizzy drink tax: can it halt the diabetes epidemic?

11th July 2014

 The fizzy drink tax: can it halt the diabetes epidemic? Articles

The International Diabetes Federation is calling for taxes on sugary drinks – with the hope of holding back the rise of type 2 diabetes. The battle to halt the global epidemics...

Read more

Forget the endpoint

1st July 2014

 Forget the endpointArticles

Forget whether a study met its endpoint, having more clinical data is always a positive outcome.The debate about whether patients with metastatic colorectal cancer (mCRC) should be treated with the...

Read more

News

US lawmakers aim to block tax inversion deals

16th July 2014

 US lawmakers aim to block tax inversion dealsNews

US companies could be blocked from reducing their corporate tax liabilities by merging with overseas companies - a process known as tax inversion - if President Obama has his way.The...

Read more

Changes to industry code of conduct in UK

15th July 2014

 Changes to industry code of conduct in UKNews

Changes to the UK pharma industry's Code of Practice are to be introduced as part of pan-European reforms to make dealings with healthcare professionals more transparent.The UK's industry association the ABPI and...

Read more

Avastin gets FDA Priority Review for advanced cervical cancers

15th July 2014

 Avastin gets FDA Priority Review for advanced cervical cancersNews

Avastin has been granted an FDA priority review for the treatment of women with persistent, recurrent or metastatic cervical cancer. Genentech's Avastin (bevacizumab) combined with chemotherapy could help advance treatment significantly in this...

Read more

NICE seeks more info on nerve damage detector

9th July 2014

 NICE seeks more info on nerve damage detectorNews

A medical device that is used to detect the early stages of nerve damage in diabetics has shown some signs of effectiveness, but not enough to warrant its routine use...

Read more

White Papers

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Engage with confidence: Managing online adverse event reporting

18th March 2014

 Engage with confidence: Managing online adverse event reportingWhite Papers

The pharmaceutical industry is waking up to the enormous potential offered by social media and other online data sources for informing better decisions around drug development and commercialization. Here, Siva...

Read more

The Healthcare Meetings Forum 2013

22nd October 2013

 The Healthcare Meetings Forum 2013White Papers

Healthcare meetings are experiencing a time of change, as new compliance regulations, the rise of digital and the flexing needs of healthcare providers force adaptation. This has raised concerns across...

Read more

Audio & Video

Rare Disease Day tweetchat

  To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click here. During the hour-long tweetchat, we covered the following questions:   1) What are...

Read more

Events

2nd Annual Sustaining Effective CAPA Systems

30th July 2014 - 31st July 2014

2nd Annual Sustaining Effective CAPA Systems

The 2nd Annual Sustaining Effective CAPA Systems Conference offers timely, innovative insight from leaders within the medical device and pharmaceutical industries – all with a level of detail and clarity...

Read more

4th International Conference on Proteomics & Bioinformatics

4th August 2014 - 6th August 2014

4th International Conference on Proteomics & Bioinformatics

event which promotes exchange of knowledge and research techniques with all the experts from pharmaceutical and biotech companies, academicians from leading universities, scientists from research institutions. It gives an opportunity...

Read more

2nd Annual MEDICAL AFFAIRS LEADERS FORUM ASIA

5th August 2014 - 6th August 2014

2nd Annual MEDICAL AFFAIRS LEADERS FORUM ASIA

Asia’s pharma market is already worth more than $200 billion and is expected to grow exponentially each year going forward. The population in Asia is over 4 billion and the...

Read more

4th Annual MARKET & PATIENT ACCESS in LATIN AMERICA

19th August 2014 - 20th August 2014

4th Annual MARKET & PATIENT ACCESS in LATIN AMERICA

This two-day event will allow all participants the ability to learn about the current market access approaches which are required for each market in order for them to have greater...

Read more

Press Releases

New WMF article on global healthcare gaps published

29th May 2014

New WMF article on global healthcare gaps published

WMF recently published an article in Pharmaceutical Physician, which looks at the shocking gaps in healthcare that exist across the world and summarises how the organisation is helping to improve...

Read more

Industry and the NHS - can promotion and partnership co-exist … a debate hosted by the PM Society Market Access Interest Group …

11th February 2014

Industry and the NHS - can promotion and partnership co-exist … a debate hosted by the PM Society Market Access Interest Group …

  Chair: Beverly Barr, Vice-Chair and Market Access Lead, PM Society Panel: Di Vegh, NHS Partnership Manager, ABPI:  How to avoid divorce in your NHS partnerships   Felicity Greene, Director of Operations at NHS South...

Read more

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

KROLL: STRATEGIES FOR IP PROTECTION AND SUCCESSFUL INVESTMENT

23rd July 2013

KROLL:  STRATEGIES FOR IP PROTECTION AND SUCCESSFUL INVESTMENT

Over the last 25 years, Kroll has been advising chemical, manufacturing and biotech companies on investigating and mitigating the loss of trade secrets and valuable intellectual property.  At a recent...

Read more